全球粒子束治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

粒子束治疗市场预计将从 2025 年的 20.2 亿美元成长到 2034 年的 38.8 亿美元，2026 年至 2034 年的复合年增长率为 7.5%。

随着先进癌症治疗技术的日益普及，全球粒子束治疗市场正蓬勃发展。粒子束治疗，包括质子治疗和碳离子治疗，是一种高精度放射疗法，能够精准靶向癌细胞，同时最大限度地减少对周围健康组织的损伤。癌症发生率的上升和对先进癌症治疗需求的不断增长是推动市场成长的主要因素。

技术进步和专业癌症治疗中心的建立正在加速粒子束疗法在全球的普及。各国政府和医疗机构正投资兴建先进的放射治疗基础设施，以改善癌症治疗效果。此外，持续的临床研究与开发以及治疗计划系统的改进，也提高了粒子束疗法的有效性和可及性。

未来，随着全球对先进癌症疗法的认知度不断提高，粒子束疗法市场预计将持续成长。持续的研发投入、技术创新以及新治疗中心的建立将推动市场成长。随着医疗体系致力于提高癌症存活率和患者生活质量，粒子束疗法有望成为现代癌症治疗的关键组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球粒子束治疗市场：依治疗类型划分

• 市场分析、洞察与预测
• 质子束疗法
• 重离子

第五章 全球粒子束治疗市场：依服务类型划分

• 市场分析、洞察与预测
• 迴旋加速器
• 同步辐射
• 同步迴旋加速器

第六章 全球粒子束治疗市场：依应用领域划分

• 市场分析、洞察与预测
• 儿童癌症
• 肺癌
• 膀胱癌
• 脑部和脊髓肿瘤（BSCT）
• 乳癌
• 胃肠道癌症
• 肝细胞癌（HCC）
• 头颈癌（HNC）
• 其他的

第七章 全球粒子束治疗市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院
• 学术和研究机构

第八章 全球粒子束治疗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • HitachiLtd
  • IBA Worldwide
  • Mevion Medical SystemsInc
  • Optivus Proton TherapyInc
  • Protom InternationalInc
  • Provision Healthcare
  • Varian Medical SystemsInc

The Particle Therapy Market size is expected to reach USD 3.88 Billion in 2034 from USD 2.02 Billion (2025) growing at a CAGR of 7.5% during 2026-2034.

The global particle therapy market is gaining momentum as advanced cancer treatment technologies become more widely adopted. Particle therapy, including proton and carbon ion therapy, is a highly precise radiation treatment used to target cancer cells while minimizing damage to surrounding healthy tissues. The growing prevalence of cancer and increasing demand for advanced oncology treatments are key factors driving market growth.

Technological advancements and the development of specialized cancer treatment centers are accelerating the adoption of particle therapy worldwide. Governments and healthcare institutions are investing in advanced radiation therapy infrastructure to improve cancer treatment outcomes. In addition, ongoing clinical research and improved treatment planning systems are enhancing the effectiveness and accessibility of particle therapy.

In the future, the particle therapy market is expected to expand as awareness of advanced cancer treatments increases globally. Continued research, technological innovation, and the establishment of new therapy centers will support market development. As healthcare systems focus on improving cancer survival rates and patient quality of life, particle therapy is likely to become an important component of modern oncology care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy

• Proton Therapy
• Heavy lon

By Services

• Cyclotrons
• Synchrotrons
• Synchrocyclotrons

By Application

• Pediatric Cancer
• Lung Cancer
• Bladder Cancer
• Brain and Spinal Cord Tumors (BSCT)
• Breast Cancer
• Gastrointestinal (GI) Cancers
• Hepatocellular Carcinoma (HCC)
• Head and Neck Cancers (HNC)
• Others

By End-User

• Hospitals
• Academic & Research Centers

COMPANIES PROFILED

• Advanced Oncotherapy PLC, Danfysik AS, Hitachi, Ltd, IBA Worldwide, Mevion Medical Systems, Inc, Optivus Proton Therapy, Inc, Protom International, Inc, Provision Healthcare, Varian Medical Systems, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PARTICLE THERAPY MARKET: BY THERAPY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy
• 4.2. Proton Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Heavy lon Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PARTICLE THERAPY MARKET: BY SERVICES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Services
• 5.2. Cyclotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Synchrotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Synchrocyclotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PARTICLE THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Pediatric Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Bladder Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Brain and Spinal Cord Tumors (BSCT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Gastrointestinal (GI) Cancers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Hepatocellular Carcinoma (HCC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Head and Neck Cancers (HNC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PARTICLE THERAPY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PARTICLE THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Therapy
  • 8.2.2 By Services
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Therapy
  • 8.3.2 By Services
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Therapy
  • 8.4.2 By Services
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Therapy
  • 8.5.2 By Services
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Therapy
  • 8.6.2 By Services
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PARTICLE THERAPY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Advanced Oncotherapy PLC
  • 10.2.2 Danfysik A/S
  • 10.2.3 HitachiLtd
  • 10.2.4 IBA Worldwide
  • 10.2.5 Mevion Medical SystemsInc
  • 10.2.6 Optivus Proton TherapyInc
  • 10.2.7 Protom InternationalInc
  • 10.2.8 Provision Healthcare
  • 10.2.9 Varian Medical SystemsInc